Bill Radvak Bill Radvak has been verified by Muck Rack's editorial team

Bill Radvak is Executive Chairman and Interim Chief Executive Officer of NervGen Pharma Corp., a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. He can be reached at [email protected]

Stay Informed with Grit Daily News!

Stay ahead of the game with Grit Daily News. Sign up now for our exclusive newsletter and be the first to know about the latest news and trends!